# OnCo record nct00248287 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00248287/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00248287", "NCT00248287" ;
  schema:name "PhII ICb With/Without Erbitux in MBC Pts"@en ;
  schema:description "A phase 2 trial of Carboplatin and Cetuximab in advanced solid tumours, run by US Oncology Research, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct00248287/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00248287> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2005-07-28" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/cetuximab/> ;
  onco:companies <https://onco.cc/companies/mckesson-us-oncology/>, <https://onco.cc/companies/bms/>, <https://onco.cc/companies/pfizer/> .